The white paper, published by European Federation of Pharmaceutical Industries and Associations (EFPIA), is intended to express views of the European-based innovative pharmaceutical industry associated within the EFPIA to combat counterfeiting.
The paper suggested that to protect against counterfeiting, basic levels of security on all prescription-only medicines should be a combination of tamper-evident packaging and a unique code for each medicine pack, based on one harmonised coding solution across Europe.
It said a unique serial number would be required to verify each pack at the point of dispensing, thus making a significant contribution to greater product security and patient safety.
EFPIA said it supports the principle of applying safety features on the outer packaging and all prescription medicines must be subject to the same level of security.
Download to find out more.